W244601
Ethyl nitrite solution
10-20 wt. % in ethanol
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
C2H5ONO
CAS Number:
Molecular Weight:
75.07
Flavis number:
16.017
MDL number:
InChI key
QQZWEECEMNQSTG-UHFFFAOYSA-N
InChI
1S/C2H5NO2/c1-2-5-3-4/h2H2,1H3
SMILES string
CCON=O
biological source
synthetic
reg. compliance
FDA 21 CFR 172.515
concentration
10-20 wt. % in ethanol
refractive index
n20/D 1.360
density
0.792 g/mL at 25 °C
organoleptic
nearly
signalword
Danger
hcodes
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2
Storage Class
3 - Flammable liquids
wgk
WGK 1
flash_point_f
59.0 °F - closed cup
flash_point_c
15 °C - closed cup
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J C MacDonald et al.
Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 35(7), 485-487 (1981-01-01)
Gas chromatography--mass spectrometry demonstrates the presence of ethyl nitrite in the breath of volunteers subjects who smoke and drink concurrently. The mutagenic compound is quantitated at the ppb level by gas chromatography with the selective electron capture detector. The compound
Alessio Baccarani et al.
Journal of reconstructive microsurgery, 23(5), 257-262 (2007-09-19)
Vasospasm leading to thrombosis is a major cause of free flap failure. Flap blood flow may improve by application of vasodilating agents to the pedicle. The purpose of this study is to evaluate the effect of a novel S-nitrosylating agent
Basil M Yurcisin et al.
Annals of surgery, 257(5), 971-977 (2013-01-31)
To determine if reduction in nitric oxide bioactivity contributes to the physiological instability that occurs after brain death and, if so, to also determine in this setting whether administration of a renitrosylating agent could improve systemic physiological status. Organ function
Martin P Moya et al.
Lancet (London, England), 360(9327), 141-143 (2002-07-20)
Inhaled nitric oxide is used to alleviate pulmonary hypertension and hypoxaemia, but generates toxic free radicals and oxides of nitrogen (NO(x)), which can cause rebound-hypoxia and additional pulmonary and other morbidity. To address these problems, we assessed the efficacy of
Richard L Auten et al.
American journal of respiratory and critical care medicine, 176(3), 291-299 (2007-05-05)
Inhaled nitric oxide (NO) has been used to prevent bronchopulmonary dysplasia, but with variable results. Ethyl nitrite (ENO) forms S-nitrosothiols more readily than does NO, and resists higher-order nitrogen oxide formation. Because S-nitrosylation is a key pathway mediating many NO
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service